← Back to Clinical Trials
Recruiting NCT07726823

NCT07726823 Comparative Effects of Mulligan Bent Leg Raise Versus Spinal Mobilization With Leg Movement in Lumbar Radiculopathy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07726823
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Lumbar Radiculopathy
Study Type INTERVENTIONAL
Enrollment 52 participants
Start Date 2026-06-20
Primary Completion 2026-08-20

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Mulligan Bent Leg Raise (MBLR)Spinal Mobilization With Leg Movement (SMWLM)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 52 participants in total. It began in 2026-06-20 with a primary completion date of 2026-08-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Lumbar radiculopathy is a spinal nerve root disorder often caused by lumbar disc herniation or compression, leading to radiating leg pain, restricted movement, and functional difficulties. This condition significantly disrupts daily activities and overall quality of life. While medication and exercise are common treatments, manual therapy techniques are gaining recognition for their non-invasive and effective outcomes in relieving symptoms and improving patient function.

Eligibility Criteria

Inclusion Criteria: * Age 20 to 40 years (26) * Diagnosed patient with Unilateral Lumbar Radiculopathy secondary to L4/L5 and L5/S1 lumbar posterolateral disc buldge confirmed on MRI (12) * Posterolateral Lumbar Radiculopathy Exclusion Criteria: * • Presence of red flags (e.g., cauda equina syndrome, severe neurological deficits). * Previous spinal surgery within 1 year. * Severe osteoporosis or vertebral fractures. * Pregnant women. * Systemic inflammatory or autoimmune diseases.

Contact & Investigator

Central Contact

Amna Zia, PhD*

✉ amna.zia@kemu.edu.pk

📞 03244686993

Principal Investigator

Amna Zia, PhD

PRINCIPAL INVESTIGATOR

King Edward Medical University

Frequently Asked Questions

Who can join the NCT07726823 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Lumbar Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07726823 currently recruiting?

Yes, NCT07726823 is actively recruiting participants. Contact the research team at amna.zia@kemu.edu.pk for enrollment information.

Where is the NCT07726823 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07726823 clinical trial?

NCT07726823 is sponsored by Riphah International University. The principal investigator is Amna Zia, PhD at King Edward Medical University. The trial plans to enroll 52 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology